Freezing heart troubles: new device aims to stop ventricular tachycardia
NCT ID NCT07650032
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new device that uses extreme cold to destroy small areas of heart tissue causing a dangerous fast heartbeat called ventricular tachycardia. The trial will include 100 adults with this condition who have not responded to medication. Researchers will check if the procedure is safe and effectively prevents the abnormal rhythm for at least 6 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cryoablation device (vCLAS Ventricular Ablation System)
What this could lead to
If successful, this could provide a new, safer way to control dangerous heart rhythms without needing lifelong medication.
What could go wrong
This is an early-stage study with only 100 people. The procedure carries risks like heart damage or bleeding, and it may not work for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTRICULAR TACHYCARDIA, MONOMORPHIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Banner University Medical Center Phoenix
Phoenix, Arizona, 85006, United States
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Hospital of University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
McGill University Health Centre (MUHC), Montreal General Hospital (MGH)
Montreal, Quebec, H3G 1A4, Canada
-
Medical Center of South Carolina (MUSC)
Charleston, South Carolina, 29403, United States
-
MemorialCare Long Beach Medical Center
Long Beach, California, 90806, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Montreal Hear Institute
Montreal, Canada
-
Northwell Health- Staten Island University Hospital
Staten Island, New York, 10305, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
-
Virginia Commonwealth University
Richmond, Virginia, 23219, United States
Contact Email: •••••@•••••